title: Cutaneous metastasis from hepatocellular carcinoma after a percutaneous interventional procedure.
authors.affiliation: Servicio de Dermatología, Hospital General Universitario de Alicante, Alicante, España. Electronic address: fjlmarrero1@gmail.com.
authors.forename: F J
authors.initials: FJ
authors.lastname: de León
authors.affiliation: Servicio de Dermatología, Hospital General Universitario de Alicante, Alicante, España.
authors.forename: M M
authors.initials: MM
authors.lastname: Blanes
authors.affiliation: Servicio de Dermatología, Hospital General Universitario de Alicante, Alicante, España.
authors.forename: M P
authors.initials: MP
authors.lastname: Albares
authors.affiliation: Servicio de Dermatología, Hospital General Universitario de Alicante, Alicante, España.
authors.forename: L
authors.initials: L
authors.lastname: Berbegal
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy / Q000209:etiology / Q000532:radiotherapy / Q000556:secondary*; D003131:Combined Modality Therapy; D003972:Diathermy / Q000009:adverse effects* / Q000295:instrumentation; D000431:Ethanol / Q000627:therapeutic use; D017809:Fatal Outcome; D019698:Hepatitis C, Chronic / Q000150:complications; D006801:Humans; D008103:Liver Cirrhosis / Q000209:etiology; D008113:Liver Neoplasms / Q000473:pathology*; D008297:Male; D009339:Needles; D009366:Neoplasm Seeding; D009536:Niacinamide / Q000031:analogs & derivatives / Q000627:therapeutic use; D010671:Phenylurea Compounds / Q000627:therapeutic use; D000078702:Radiofrequency Therapy; D012597:Sclerosing Solutions / Q000627:therapeutic use; D012878:Skin Neoplasms / Q000188:drug therapy / Q000209:etiology / Q000532:radiotherapy / Q000556:secondary*; D000077157:Sorafenib
chemical_list: D000970:Antineoplastic Agents; D010671:Phenylurea Compounds; D012597:Sclerosing Solutions; D009536:Niacinamide; D000431:Ethanol; D000077157:Sorafenib